Enhua Wang Selected Research

Catenins

1/2019	CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
1/2018	TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling.
1/2017	Dact3 inhibits the malignant phenotype of non-small cell lung cancer through downregulation of c-Myb.
6/2015	Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1.
12/2014	C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
10/2014	TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.
1/2014	Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
1/2014	Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the Wnt/β-catenin signaling pathway.
8/2013	Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
8/2013	Clinical and prognostic significance of Yes-associated protein in colorectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enhua Wang Research Topics

Disease

102	Neoplasms (Cancer) 11/2021 - 08/2002
53	Lung Neoplasms (Lung Cancer) 11/2021 - 05/2003
52	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 02/2003
30	Lymphatic Metastasis 11/2014 - 08/2002
26	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2002
25	Breast Neoplasms (Breast Cancer) 05/2022 - 08/2007
10	Adenocarcinoma 11/2014 - 02/2004
10	Carcinogenesis 09/2014 - 02/2004
9	Adenocarcinoma of Lung 09/2020 - 10/2008
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011 - 02/2004
4	Fanconi Anemia (Fanconi's Anemia) 05/2022 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 06/2013
4	Carcinoma (Carcinomatosis) 05/2015 - 08/2002
3	Urinary Bladder Neoplasms (Bladder Cancer) 03/2017 - 11/2012
3	Ovarian Neoplasms (Ovarian Cancer) 10/2015 - 01/2012
3	Ovarian Epithelial Carcinoma 08/2014 - 01/2012
3	Pulmonary Sclerosing Hemangioma 04/2006 - 04/2003
2	Stomach Neoplasms (Stomach Cancer) 04/2019 - 01/2017
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2013 - 11/2012
2	Inflammation (Inflammations) 01/2013 - 11/2011
2	Hypoxia (Hypoxemia) 10/2008 - 10/2008
2	Giant Cell Carcinoma 06/2008 - 04/2008
1	COVID-19 10/2021
1	Infections 10/2021
1	Starvation 08/2020

Drug/Important Bio-Agent (IBA)

55	Proteins (Proteins, Gene)FDA Link 11/2021 - 08/2002
30	Biological ProductsIBA 04/2019 - 08/2005
21	Cadherins (E-Cadherin)IBA 01/2018 - 08/2002
20	CateninsIBA 01/2019 - 02/2004
16	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2008
14	Messenger RNA (mRNA)IBA 11/2021 - 08/2002
14	Delta CateninIBA 01/2018 - 08/2005
9	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 03/2009
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2012
9	Cyclin D1IBA 01/2018 - 01/2012
7	Pharmaceutical PreparationsIBA 11/2015 - 01/2012
6	Phosphotransferases (Kinase)IBA 11/2021 - 10/2011
6	VimentinIBA 08/2015 - 04/2004
5	Protein Isoforms (Isoforms)IBA 01/2014 - 04/2008
5	MicroRNAs (MicroRNA)IBA 06/2013 - 09/2009
5	beta CateninIBA 09/2010 - 08/2002
4	AntibodiesIBA 10/2021 - 06/2005
3	Keratins (Keratin)IBA 01/2021 - 04/2004
3	Caspase 3 (Caspase-3)IBA 08/2020 - 08/2012
3	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 08/2013
3	Matrix Metalloproteinases (MMPs)IBA 03/2017 - 01/2014
3	MethyltransferasesIBA 09/2015 - 01/2012
3	DesminIBA 08/2015 - 01/2015
3	AntigensIBA 09/2012 - 02/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2009 - 01/2009
3	Vascular Endothelial Growth Factor CIBA 08/2009 - 05/2003
2	Alkylating AgentsIBA 05/2022 - 07/2014
2	Neurofibromin 2 (Merlin)IBA 11/2021 - 01/2020
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2021 - 04/2004
2	Long Noncoding RNAIBA 09/2020 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2018 - 01/2014
2	NF-kappa B (NF-kB)IBA 02/2018 - 01/2012
2	Cyclin A2IBA 01/2018 - 09/2015
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 07/2013
2	ErbB Receptors (EGF Receptor)IBA 08/2016 - 01/2013
2	Estrogen Receptor alphaIBA 09/2015 - 09/2012
2	Methionine EnkephalinIBA 01/2015 - 03/2014
2	AnthracyclinesIBA 01/2015 - 09/2012
2	Adenosine Triphosphate (ATP)IBA 01/2015 - 06/2013
2	Chemokine ReceptorsIBA 12/2014 - 10/2008
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 06/2013
2	TNF Receptor-Associated Factor 4IBA 10/2014 - 06/2013
2	SurvivinIBA 07/2014 - 08/2012
2	Caspase 8 (Caspase-8)IBA 07/2014 - 11/2013
2	Indicators and Reagents (Reagents)IBA 12/2013 - 01/2013
2	A-Form DNA (A-DNA)IBA 09/2013 - 01/2012
2	Guanosine Triphosphate (GTP)IBA 05/2013 - 05/2009
2	CytokinesIBA 01/2013 - 08/2012
2	VaccinesIBA 11/2012 - 09/2012
2	Cyclin EIBA 10/2012 - 01/2012
2	Estrogens (Estrogen)FDA Link 09/2012 - 09/2012
2	Focal Adhesion Kinase 2IBA 08/2012 - 12/2008
2	ParaffinIBA 08/2012 - 10/2004
2	Formaldehyde (Formol)FDA Link 08/2012 - 10/2004
2	CC ChemokinesIBA 01/2012 - 01/2011
2	Interleukin-7 (Interleukin 7)IBA 01/2012 - 03/2009
2	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2012 - 03/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2011 - 06/2007
2	integrin-linked kinaseIBA 01/2011 - 08/2005
2	heparanaseIBA 08/2009 - 02/2004
2	Monomeric GTP-Binding ProteinsIBA 05/2009 - 04/2009
2	Guanine NucleotidesIBA 08/2008 - 06/2008
2	Biological FactorsIBA 12/2004 - 02/2004
2	IgA receptor (protein B)IBA 04/2004 - 04/2003
2	Surface-Active Agents (Surfactants)IBA 04/2004 - 04/2003
1	Cysteine (L-Cysteine)FDA Link 11/2021
1	Inhibins (Inhibin)IBA 11/2021
1	Connective Tissue Growth FactorIBA 11/2021
1	Rituximab (Mabthera)FDA Link 10/2021
1	Carrier Proteins (Binding Protein)IBA 09/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2021

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 11/2015 - 02/2003
9	Therapeutics 05/2016 - 09/2010
3	Immunotherapy 01/2015 - 11/2012
2	Radiotherapy 08/2017 - 08/2012